[144] Wesco International Inc. SEC Filing

Rhea-AI Filing Summary

Wesco International Inc. insider Christine Wolf notified the SEC of a proposed sale under Rule 144 of 2,098 common shares via UBS Financial Services with an aggregate market value of $471,881, with an approximate sale date of 08/27/2025. The shares were acquired by a SAR exercise on 08/26/2025 and payment was recorded on 08/27/2025. The filing also discloses that Christine Wolf sold 3,106 shares on 06/18/2025 for gross proceeds of $550,217; the notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR Insider filed a routine Rule 144 notice for SAR-derived shares to be sold through UBS; prior sale in June was also disclosed.

The filing documents a planned sale of 2,098 common shares acquired by a stock appreciation right exercise one day earlier, indicating a rapid disposition under Rule 144 through a broker-dealer. The disclosed aggregate market value of $471,881 and a prior sale of 3,106 shares for $550,217 on 06/18/2025 are explicit facts. This appears to be a compliance disclosure rather than a corporate operational event; there is no statement of undisclosed material adverse information. For investors, the filing confirms insider liquidity activity but does not by itself indicate company-level financial change.

Corporate Governance Expert

TL;DR Routine insider sale notice under Rule 144; shows compliance with disclosure rules and an earlier insider sale this year.

The document shows adherence to Rule 144 reporting for sales aggregated with prior transactions. The immediate sale of shares obtained from a SAR exercise suggests use of standard compensation monetization. The seller’s signed representation that no undisclosed adverse information exists is included. From a governance perspective, this is a procedural disclosure that supports transparency but does not imply operational or governance concerns based on the information provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	2098	471881	48662715	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/26/2025	SAR exercise	Issuer			2098	08/27/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christine Wolf 225 West Station Square Drive Suite 700 Pittsburgh PA 15219	Common	06/18/2025	3106	550217

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Wesco International (WCC) report in this Form 144?

The filing reports a proposed sale of 2,098 common shares via UBS with an aggregate market value of $471,881, and notes a prior sale of 3,106 shares on 06/18/2025 for $550,217.

Who is the seller named in the Form 144 for WCC?

The seller listed is Christine Wolf, with an address in Pittsburgh, PA, shown for prior sales disclosure.

How were the 2,098 shares acquired according to the filing?

The shares were acquired by a SAR exercise on 08/26/2025, with the date of payment recorded as 08/27/2025.

Through which broker will the sale be executed?

The sale is to be executed through UBS Financial Services Inc. at 1000 Harbor Blvd, Weehawken, NJ, on the NYSE.

Does the filing state any undisclosed material adverse information?

By signing the notice, the person represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.